Literature DB >> 10706960

Is there a causal link between hepatitis B vaccination and multiple sclerosis?

P Monteyne1, F E André.   

Abstract

After the publication of case reports of hepatitis B vaccinees with onset or relapse of multiple sclerosis (MS), followed by a media-driven scare campaign in France, the perception that hepatitis B vaccine causes MS has developed. This has led to a fall in the acceptance of hepatitis B vaccination particularly in French-speaking communities which was accelerated by court decisions in favour of vaccination "victims" and the suspension of routine vaccination of pre-adolescents in French schools as a "precautionary measure". This situation has arisen in spite of the absence of scientific data to support a causal link between vaccination and multiple sclerosis. In this article, initially written to inform and reassure employees of one of the vaccine manufacturers, the epidemiological importance of hepatitis B and current knowledge on the aetiology of MS are described. All available data that may throw light on the hypothesis that hepatitis B vaccination is causally linked to MS was reviewed. The conclusion reached on the basis of available data is that the most plausible explanation for the observed temporal association between vaccination and MS is that it is a coincidental association. It is now important to rebuild public confidence in hepatitis B vaccine as well as in vaccination in general.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706960     DOI: 10.1016/s0264-410x(99)00533-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Demyelinating disease and hepatitis B vaccination: is there a link?

Authors:  T Jefferson; H Heijbel
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Probable epitopes: Relationships between myelin basic protein antigenic determinants and viral and bacterial proteins.

Authors:  Lindsay Klee; Robert Zand
Journal:  Neuroinformatics       Date:  2004

Review 3.  [Vaccination and multiple sclerosis].

Authors:  M Löbermann; A Winkelmann; E C Reisinger; U K Zettl
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 4.  Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.

Authors:  Yahel Segal; Yehuda Shoenfeld
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

Review 5.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 6.  Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics.

Authors:  Gregory A Poland; Robert M Jacobson; Inna G Ovsyannikova
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

7.  Demonstration of background rates of three conditions of interest for vaccine safety surveillance.

Authors:  Anne E Wormsbecker; Caitlin Johnson; Laura Bourns; Tara Harris; Natasha S Crowcroft; Shelley L Deeks
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.